Drug Shortage Report for TEVA-BUDESONIDE
| Report ID | 195478 |
| Drug Identification Number | 02465957 |
| Brand name | TEVA-BUDESONIDE |
| Common or Proper name | TEVA-BUDESONIDE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 0.5MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 20 |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-19 |
| Estimated end date | 2025-03-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-03-25 |
| Company comments | Product is under allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v60 | 2025-03-25 | French | Compare |
| v59 | 2025-03-25 | English | Compare |
| v58 | 2025-03-13 | French | Compare |
| v57 | 2025-03-13 | English | Compare |
| v56 | 2025-03-10 | French | Compare |
| v55 | 2025-03-10 | English | Compare |
| v54 | 2025-03-03 | French | Compare |
| v53 | 2025-03-03 | English | Compare |
| v52 | 2025-02-28 | French | Compare |
| v51 | 2025-02-28 | English | Compare |
| v50 | 2025-02-20 | French | Compare |
| v49 | 2025-02-20 | English | Compare |
| v48 | 2025-02-06 | French | Compare |
| v47 | 2025-02-06 | English | Compare |
| v46 | 2025-01-15 | French | Compare |
| v45 | 2025-01-15 | English | Compare |
| v44 | 2025-01-15 | English | Compare |
| v43 | 2024-11-21 | French | Compare |
| v42 | 2024-11-21 | English | Compare |
| v41 | 2024-11-14 | French | Compare |